New York's Governor Andrew Cuomo has limited the prescription of the drug to individuals who meet certain FDA criteria.
New York is moving at breakneck speed to test antimalarial drugs that have previously been touted by President Trump as a "game changer" on critically ill coronavirus patients in hopes of finding an effective treatment against the deadly virus.
Such an undertaking “is something that normally would have been done in six to nine months and we’re doing it in three or four days,” a New York state health official told The Washington Post.
According to the state, three drugs will be used: hydroxychloroquine, chloroquine — both antimalarial drugs — and the antibiotic azithromycin. The first group of patients will receive hydroxychloroquine and azithromycin, a combination that proved effective in a small, controversial study in France.
Some states, like Nevada, have filed executive orders banning prescriptions of the drugs to fight COVID-19 until more comprehensive studies are established.